Chan CHF - Search Results

1

Retrospective study of testosterone deficiency and symptom burden in patients with pancreatic cancer.

Kazarian AG, Conger HK, Mott SL, Loeffler BT, Dempewolf SM, Coleman KL, Pearlman AM, Chan CHF, Talbert EE. Kazarian AG, et al. Among authors: chan chf. Transl Androl Urol. 2023 Jul 31;12(7):1079-1089. doi: 10.21037/tau-22-684. Epub 2023 Jul 28. Transl Androl Urol. 2023. PMID: 37554534 Free PMC article.

2

Peritoneal Cell-Free Tumor DNA is a Biomarker of Locoregional and Peritoneal Recurrence in Resected Pancreatic Ductal Adenocarcinomas.

Leick KM, Tomanek-Chalkley A, Coleman KL, Chan CHF. Leick KM, et al. Among authors: chan chf. Ann Surg Oncol. 2023 Oct;30(11):6652-6660. doi: 10.1245/s10434-023-13701-2. Epub 2023 Jun 11. Ann Surg Oncol. 2023. PMID: 37303025

3

[No title available]

[No authors listed] [No authors listed] PMID: 37423929

4

Machine-learning based investigation of prognostic indicators for oncological outcome of pancreatic ductal adenocarcinoma.

Chang J, Liu Y, Saey SA, Chang KC, Shrader HR, Steckly KL, Rajput M, Sonka M, Chan CHF. Chang J, et al. Among authors: chan chf. Front Oncol. 2022 Dec 8;12:895515. doi: 10.3389/fonc.2022.895515. eCollection 2022. Front Oncol. 2022. PMID: 36568148 Free PMC article.

5

A luminescent sensor for investigating serotonin metabolism in neuroendocrine cancer.

Tow DH, Chan CH, Howe JR, Ear PH. Tow DH, et al. Surgery. 2024 Mar;175(3):726-734. doi: 10.1016/j.surg.2023.09.018. Epub 2023 Oct 31. Surgery. 2024. PMID: 37914574

6

Gastroenteropancreatic neuroendocrine carcinoma tumor spheroid drug screen reveals vulnerability to tyrosyl-DNA phosphodiesterase 1 inhibitors.

Beyer GV, Hueser S, Li R, Manika D, Lee M, Chan CHF, Howe JR, Ear PH. Beyer GV, et al. Among authors: chan chf. Surgery. 2024 Mar;175(3):605-612. doi: 10.1016/j.surg.2023.08.044. Epub 2023 Oct 31. Surgery. 2024. PMID: 37914572

7

Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer.

Chau J, Yadav M, Liu B, Furqan M, Dai Q, Shahi S, Gupta A, Mercer KN, Eastman E, Hejleh TA, Chan C, Weiner GJ, Cherwin C, Lee STM, Zhong C, Mangalam A, Zhang J. Chau J, et al. BMC Cancer. 2021 Jul 13;21(1):808. doi: 10.1186/s12885-021-08530-z. BMC Cancer. 2021. PMID: 34256732 Free PMC article.

8

Expression of cancer stem cell markers in tall cell variant papillary thyroid cancer identifies a molecular profile predictive of recurrence in classic papillary thyroid cancer.

Beck AC, Rajan A, Landers S, Kelley S, Bellizzi AM, Lal G, Sugg SL, Howe JR, Chan CH, Weigel RJ. Beck AC, et al. Surgery. 2022 Jan;171(1):245-251. doi: 10.1016/j.surg.2021.03.076. Epub 2021 Aug 3. Surgery. 2022. PMID: 34362588

9

CHEK2 Founder Variants and Thyroid Cancer Risk.

Brock P, Liynarachchi S, Nieminen TT, Chan C, Kohlmann W, Stout LA, Yao S, La Greca A, Jensen KE, Kolesar JM, Salhia B, Gulhati P, Hicks JK, Ringel MD. Brock P, et al. Thyroid. 2024 Apr;34(4):477-483. doi: 10.1089/thy.2023.0529. Epub 2024 Feb 27. Thyroid. 2024. PMID: 38279823

10

Rapid and Sensitive Detection of Breast Cancer Cells in Patient Blood with Nuclease-Activated Probe Technology.

Kruspe S, Dickey DD, Urak KT, Blanco GN, Miller MJ, Clark KC, Burghardt E, Gutierrez WR, Phadke SD, Kamboj S, Ginader T, Smith BJ, Grimm SK, Schappet J, Ozer H, Thomas A, McNamara JO 2nd, Chan CH, Giangrande PH. Kruspe S, et al. Mol Ther Nucleic Acids. 2017 Sep 15;8:542-557. doi: 10.1016/j.omtn.2017.08.004. Epub 2017 Aug 12. Mol Ther Nucleic Acids. 2017. PMID: 28918054 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page